Steven H. Holtzman

2009 - Infinity Pharmaceuticals

In 2009, Steven H. Holtzman earned a total compensation of $1M as Executive Chair at Infinity Pharmaceuticals, a 24% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$208,000
Option Awards$299,200
Salary$520,000
Other$7,782
Total$1,034,982

Holtzman received $520K in salary, accounting for 50% of the total pay in 2009.

Holtzman also received $208K in non-equity incentive plan, $299.2K in option awards and $7.8K in other compensation.

Rankings

In 2009, Steven H. Holtzman's compensation ranked 4,342nd out of 9,885 executives tracked by ExecPay. In other words, Holtzman earned more than 56.1% of executives.

ClassificationRankingPercentile
All
4,342
out of 9,885
56th
Division
Manufacturing
1,549
out of 3,690
58th
Major group
Chemicals And Allied Products
297
out of 866
66th
Industry group
Drugs
181
out of 638
72nd
Industry
Pharmaceutical Preparations
143
out of 446
68th
Source: SEC filing on April 11, 2011.

Holtzman's colleagues

We found three more compensation records of executives who worked with Steven H. Holtzman at Infinity Pharmaceuticals in 2009.

2009

Adelene Perkins

Infinity Pharmaceuticals

Chief Executive Officer

2009

Julian Adams

Infinity Pharmaceuticals

President of R&D

2009

Vito Palombella

Infinity Pharmaceuticals

Chief Scientific Officer

You may also like